학술논문
Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors
Document Type
Article
Author
Source
In: Cancer Chemotherapy and Pharmacology . (Cancer Chemotherapy and Pharmacology, December 2013, 72(6):1213-1222)
Subject
Language
English
ISSN
03445704
14320843
14320843